Pictet Asset Management Sa Seres Therapeutics, Inc. Call Options Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MCRB
# of Institutions
9Shares Held
1.98MCall Options Held
10KPut Options Held
0-
Black Rock Inc. New York, NY1.76MShares$27.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY150KShares$2.31 Million0.0% of portfolio
-
Kestra Advisory Services, LLC38.5KShares$593,9920.0% of portfolio
-
Miller Financial Services LLC Marshall, MI15KShares$231,6000.02% of portfolio
-
Jpmorgan Chase & CO New York, NY1.3KShares$20,1330.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.92B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...